Conference
Should we routinely screen for frailty prior to gynecologic oncology surgery? Frailty as a potential predictor of adverse postoperative outcomes in elderly patients.
Abstract
6517
Background: Frailty is increasingly recognized as an adverse prognostic factor of postoperative morbidity and survival in several surgical disciplines. There is no consensus on routine frailty screening in Gynecologic Oncology. Our goal was to evaluate the predictive role of the National Surgical Quality Improvement Program(NSQIP) comorbidity-based modified Frailty Index-5(mFI-5) in Gynecologic Oncology patients over the …
Authors
Mah S; Anpalagan T; Marcucci M; Reade C; Jimenez W; Eiriksson LR; Carlson V; Walker M; Van Nguyen JM
Volume
39
Pagination
pp. 6517-6517
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2021
DOI
10.1200/jco.2021.39.15_suppl.6517
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X